Journal of Clinical Oncology

Comment on the Definition and Interpretation of Complete Mesocolic Excision in the RELARC Trial

W Willemijn A. Jongsma (Willemijn A. Jongsma, MD, and Alexander A.J. Grüter, MD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands, Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands; Boudewijn R. Toorenvliet, MD, PhD, Ikazia Hospital, Department of Surgery, Rotterdam, the Netherlands; Jurriaan B. Tuynman, MD, PhD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands; and Pieter J. Tanis,...) A Alexander A.J. Grüter (Willemijn A. Jongsma, MD, and Alexander A.J. Grüter, MD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands, Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands; Boudewijn R. Toorenvliet, MD, PhD, Ikazia Hospital, Department of Surgery, Rotterdam, the Netherlands; Jurriaan B. Tuynman, MD, PhD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands; and Pieter J. Tanis,...) B Boudewijn R. Toorenvliet (Willemijn A. Jongsma, MD, and Alexander A.J. Grüter, MD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands, Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands; Boudewijn R. Toorenvliet, MD, PhD, Ikazia Hospital, Department of Surgery, Rotterdam, the Netherlands; Jurriaan B. Tuynman, MD, PhD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands; and Pieter J. Tanis,...) J Jurriaan B. Tuynman P Pieter J. Tanis
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 6
Published February 20, 2025
Pages 763-764
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (5)

W

Willemijn A. Jongsma

Willemijn A. Jongsma, MD, and Alexander A.J. Grüter, MD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands, Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands; Boudewijn R. Toorenvliet, MD, PhD, Ikazia Hospital, Department of Surgery, Rotterdam, the Netherlands; Jurriaan B. Tuynman, MD, PhD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands; and Pieter J. Tanis,...

A

Alexander A.J. Grüter

Willemijn A. Jongsma, MD, and Alexander A.J. Grüter, MD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands, Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands; Boudewijn R. Toorenvliet, MD, PhD, Ikazia Hospital, Department of Surgery, Rotterdam, the Netherlands; Jurriaan B. Tuynman, MD, PhD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands; and Pieter J. Tanis,...

B

Boudewijn R. Toorenvliet

Willemijn A. Jongsma, MD, and Alexander A.J. Grüter, MD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands, Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands; Boudewijn R. Toorenvliet, MD, PhD, Ikazia Hospital, Department of Surgery, Rotterdam, the Netherlands; Jurriaan B. Tuynman, MD, PhD, Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands; and Pieter J. Tanis,...

J

Jurriaan B. Tuynman

P

Pieter J. Tanis

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001